Elon, ExplainedNeuralink / TelepathyAll explainers →
Neuralink · 5 min read · In Development · 2024

Telepathy

A brain implant that lets people with paralysis control devices by thought

Telepathy is a brain implant from Neuralink that lets people with paralysis control computers, phones, and robotic limbs using thought alone. It is the company's first product, and at its center sits a coin-sized device called the N1 implant. The implant reads the electrical activity in the part of the brain that plans hand and arm movement, then turns that intended motion into digital commands. For someone whose spinal cord can no longer carry those signals, the implant routes the intention around the damage and out to a machine, which is why the first patient could beat his friends at games something he says really should not have been possible.

What is Telepathy?

Telepathy is a brain-computer interface (BCI), which is a system that reads activity straight from the brain and turns it into commands a device can follow. Neuralink calls the people who receive it "Neuralnauts." The first of them, Noland Arbaugh, a quadriplegic man, received the implant on January 28, 2024, and within days he could move a cursor just by thinking about it. On a company livestream he put it plainly: "Now I'm beating my friends at games, which really shouldn't be possible but it is."

Why Telepathy Exists

Neuralink was incorporated in 2016, founded by Elon Musk with a team of neuroscientists and engineers, and seeded with roughly $100 million of his own money. The reason for it comes in two parts, one near and one far off. Near term, the goal is to restore movement and communication to people with spinal cord injuries or amyotrophic lateral sclerosis (ALS), a disease that slowly paralyzes the muscles, including the ones used to speak. Long term, the goal is to build a high-bandwidth link between the human brain and artificial intelligence, so people are not left behind by machines that think faster than they do. Elon has summed up the bet in five words: "If you can't beat 'em, join 'em." Telepathy is the near-term, usable step toward that much larger goal.

How it Works

The hardware is a coin-sized capsule, about the width of a US quarter, set into the skull behind the ear. You cannot see it from the outside, it recharges wirelessly, and no wires ever pass through the skin. From it run 64 ultra-flexible polymer threads, each one thinner than a human hair, carrying 1,024 electrodes that listen in on the part of the brain that controls the hands and arms. A surgical robot named R1 places those threads with a precision no human hand can match. The implant picks up the pattern that fires when you intend to move, then sends that intention out over a wireless link as a digital command.

Neuralink plans to nearly triple the electrode count, which is the listening capacity that decides how much of the brain's signal the device can hear at once. More electrodes means more bandwidth, and bandwidth is what turns a cursor into a keyboard, and eventually a keyboard into a voice.

The N1 implant is set to nearly triple its electrode count

The Economics of Telepathy

Neuralink is privately funded. Elon Musk seeded it, and in mid-2025 the company closed a $650 million Series E round at a roughly $9.6 billion post-money valuation, with the money set aside for scaling up human trials and for the nearly fully automated surgeries that bring the cost per implant down as the number of implants climbs. The group of people who could use this is vast: about 18,000 new spinal cord injuries in the United States each year, and some 302,000 Americans living with one already. The price of the implant and the procedure has not been shared yet, because Telepathy is still a research trial, not a product you can buy.

The State of Telepathy Today

Two years in, in its "Two Years of Telepathy" update marking the January 28 anniversary, Neuralink reported more than 27 participants enrolled worldwide, with zero serious device-related adverse events. The pace says even more than the headcount does: three participants in all of 2024, and then multiple implants per month through 2025.

Neuralink trial enrollment accelerated sharply in year two

These are not laboratory curiosities, they are people getting their lives back. Arbaugh returned to college for a neuroscience degree and called it the best semester, grade-wise, he has ever had. Nick, unable to move his limbs for four years, used a thought-driven robotic arm to feed himself and scratch an itch. Sebastian, a 23-year-old medical student, runs his implant up to 17 hours a day. Audrey, the first female participant, took up digital art after nearly two decades of being unable to control a computer. And in his first week, Nick cleared an information-transfer rate above 10 bits per second, which matches an able-bodied person using a mouse.

Telepathy matched able-bodied mouse control in week one

What Comes Next

The current ceiling is up to 40 words per minute, typed by imagining finger movements, a "keyboard for the mind." In October 2025, Neuralink launched the VOICE trial, a speech-restoration study aiming at conversational speed. The gap between typing and natural conversation is the next mountain to climb, and it matters most for ALS patients, who eventually lose the ability to speak at all. The roadmap also includes the electrode upgrade and the nearly fully automated surgeries planned for 2026.

The Bottom Line

Telepathy has taken the long-promised idea of mind-controlled machines and turned it into a working medical device, one that gives paralyzed people their digital lives back, with a clean safety record across more than 27 people and a clear path from cursor to conversation. Whether it becomes the doorway to Elon's brain-AI "symbiosis" or stays a profound assistive technology, the near-term numbers, more electrodes, more participants, and falling surgical cost, are already moving in one direction. Only Elon would fund the machine that reads the mind, and then hand it to the people the world had written off.

Related

Keep reading: Blindsight, N1 Implant. Zoom out to the Neuralink overview, or open the Glossary.

Timeline

  • 2016 July: Neuralink incorporated by Elon Musk with a team of neuroscientists and engineers, running in stealth.
  • 2017 April: Public reveal; mission stated as treating brain disease and achieving human-AI symbiosis.
  • 2019 July: First public presentation of the flexible electrode threads and the surgical robot.
  • 2020 August: Live pig demonstration ('Gertrude') shows real-time neural signal acquisition.
  • 2021 April: Monkey shown playing Pong using thoughts alone via the implant.
  • 2023 May 25: FDA clears Neuralink's Investigational Device Exemption to begin first-in-human trials.
  • 2023 September: PRIME Study opens recruitment.
  • 2024 January 28: First human implant; Noland Arbaugh receives the N1 implant at Barrow Neurological Institute.
  • 2024 July: Second participant implanted.
  • 2024 September: Blindsight vision-restoration implant receives FDA Breakthrough Device Designation.
  • 2025 May: FDA Breakthrough Device Designation granted for a speech-restoration module.
  • 2025 June: Series E raises $650 million at roughly $9.6 billion post-money valuation.
  • 2025 October: VOICE speech-restoration trial launches, targeting conversational speed.
  • 2026 January 28: 'Two Years of Telepathy' update reports 27+ participants enrolled, up to 40 wpm typing, and zero serious device-related adverse events.

Sources

Go deeperRead the Neuralink investor brief
Keep exploring